Friday, September 23, 2011 3:11:16 PM
We had a 42 on Monday before the little trading session up to around 6. This still has a chance of being the bottom around here and could turn. Same chance of it really getting into the lows down in the 3's or worse. Flip a coin.
Not really going to do much I don't think for a bit. Most are either traded out, bought back in, and/or just waiting for more direction from the company. Maybe another little small run before it really goes in one direction or the other.
As good of possibilities as anything else around. Getting harder to find a good group of plays, investments, etc. The whole pinky market is going through a transformation, going to take time for that. The big boys aren't doing the greatest either. You have big trucking companies acting like little rinse and repeat pinks.
If the company can come up with a good plan of attack, keep their funding, usage of cash, continue to be a reporting company, it has a chance.
Still going to have to muster up some good sentiment of SNGX in the market and lack of it can crush it. Hard to call exactly and just have to wait it out.
Recent SNGX News
- Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease • PR Newswire (US) • 11/14/2024 12:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2024 09:14:25 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2024 09:12:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2024 09:10:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 09:06:03 PM
- Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results • PR Newswire (US) • 11/08/2024 12:30:00 PM
- Soligenix, Inc. to Present at the 2024 ThinkEquity Conference • GlobeNewswire Inc. • 10/24/2024 11:30:00 AM
- Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin • PR Newswire (US) • 10/22/2024 11:30:00 AM
- Soligenix Invited to Present at Upcoming Investor Conferences • PR Newswire (US) • 10/16/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:05:22 PM
- HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference • PR Newswire (US) • 10/07/2024 11:30:00 AM
- Soligenix Announces Partnership with Sterling Pharma Solutions • PR Newswire (US) • 10/03/2024 11:30:00 AM
- Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024 • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Soligenix Receives European Patent for Improved Production of Synthetic Hypericin • PR Newswire (US) • 09/03/2024 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2024 08:19:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:13:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/09/2024 08:09:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/09/2024 08:07:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:05:32 PM
- Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results • PR Newswire (US) • 08/09/2024 11:30:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/05/2024 04:15:07 AM
- Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone • GlobeNewswire Inc. • 08/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 11:30:14 AM
- PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results • GlobeNewswire Inc. • 07/15/2024 02:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 05:28:54 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM